Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Always personalize this range by having a consult with a healthcare provider
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
This gives me the right amount of jitters and drive to get through my workout
Consultation Fee: $99 Provider evaluation required Telehealth available throughout South Florida People researching BPC-157 are often interested in recovery support, active lifestyle wellness, healthy aging, and overall wellness optimization
Tesamorelin is a stabilized GHRH analog built on the full 44-amino acid GHRH sequence with a chemical modification (a trans-3-hexenoic acid group) added to its N-terminus
In in vitro inflammatory models, this tripeptide consistently downregulates the expression of pro-inflammatory cytokines, allowing researchers to study cellular homeostasis and immune pathway modulation
US$ 21.00
US$ 26.45
US$ 27.59
